The objective is to examine whether F‐FP‐CIT are broadly utilized radiotracers in sub-atomic imaging for Parkinson’s infection (PD) analysis. Contrasted and 123I‐FP‐CIT, 18F‐FP‐CIT has unrivaled tracer energy. We meant to lead a meta‐analysis to evaluate the adequacy of utilizing 18F‐FP‐CIT positron emission tomography (PET) and 123I‐FP‐CIT single‐photon emission computed tomography (SPECT) of dopamine carriers in patients with PD to give proof to clinical decision‐making. Parkinson’s disease (PD) is the second most regular neurodegenerative disorder.1 Its overwhelming obsessive component is the degeneration of dopaminergic neurons anticipating from the substantia nigra standards compacta in the midbrain to the striatum (caudate and putamen core). It clinically gives engine weakness, including unbending nature, bradykinesia, resting quake, and postural irregularity. We looked through the PubMed, Embase, Wanfang Data, and China National Knowledge Infrastructure information bases to distinguish the pertinent investigations from the hour of origin of the data sets to 30 April 2020. We distinguished six PET examinations, incorporating 779 patients with PD and 124 solid controls, which met the consideration rules. Twenty‐seven SPECT concentrates with 1244 PD patients and 859 controls were likewise remembered for this meta‐analysis.
Reference link- https://onlinelibrary.wiley.com/doi/10.1002/acn3.51122
